Home

Our Technology

Our platform technology unlocks the robust immuno-resolving properties of naturally occurring lipids to create novel, non-immunosuppressive therapies for treatment of Inflammatory Bowel Disease (IBD).

Proven Lipid Biology

Harnessing the robust immuno-resolving properties of endogenous bioactive lipids

HEALER™ Platform

Chemically transforming endogenous bioactive lipids into new chemical entities with superior pharmaceutical properties

Intellectual Property

Long-term composition of matter patent protection on Thetis agents via the HEALER platform

"We are committed to creating innovative products that improve the lives of patients suffering from IBD."

Our Approach

Thetis agents offer a unique disease-modifying approach to IBD treatment based on resolving inflammation and promoting tissue repair and healing without suppressing normal immune function.